Gpnmb mRNA increased with development of obesity until 30 weeks of age, i.e. the peak of body weight in control OLETF rats, and it declined at 50 weeks of age in both subdermal and visceral WATs (Fig. 1a). Here, GPNMB is linked to obesity disorder.